Recently, a great interest has been paid to the development of hybrid protein-inorganic
nanoparticles (NPs) for drug delivery and cancer diagnostics in order to combine the merits …

Recently, the potential use of nanoparticles for the targeted delivery of therapeutic and
diagnostic agents has garnered increased interest. Several nanoparticle drug delivery …

The development of drug delivery systems using nanoparticles as carriers for small and
large therapeutic molecules remains a rapidly growing area of research. The advantages of …

Engineered nanoparticles that can facilitate drug formulation and passively target tumours
have been under extensive research in recent years. These successes have driven a new …

In recent years, it has become apparent that cancer nanomedicine's reliance on synthetic
nanoparticles as drug delivery systems has resulted in limited clinical outcomes. This is …

Protein-based nanocarriers have gained considerable attention as colloidal carrier systems
for the delivery of anticancer drugs. Protein nanocarriers possess various advantages …

Cancer notably carcinoma represents a prominent health challenge worldwide. A variety of
chemotherapeutic agents are being used to deal with a variety of carcinomas. However …

Due to their intrinsic physical properties potentially useful for imaging and therapy as well as
their highly engineerable surface, biocompatible inorganic nanoparticles offer novel …

Cancer has been a serious threat to human health. Among drug delivery carriers, protein
nanoparticles are unique because of their mild and environmentally friendly preparation …

Nanoparticles have increasingly been used for a variety of applications, most notably for the
delivery of therapeutic and diagnostic agents. A large number of nanoparticle drug delivery …